IL139592A - Pharmaceutical composition containing an atypical antipsychotic and a serotonin reuptake inhibitor for combination therapy of refractory depression - Google Patents
Pharmaceutical composition containing an atypical antipsychotic and a serotonin reuptake inhibitor for combination therapy of refractory depressionInfo
- Publication number
- IL139592A IL139592A IL13959299A IL13959299A IL139592A IL 139592 A IL139592 A IL 139592A IL 13959299 A IL13959299 A IL 13959299A IL 13959299 A IL13959299 A IL 13959299A IL 139592 A IL139592 A IL 139592A
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical composition
- composition containing
- combination therapy
- serotonin reuptake
- reuptake inhibitor
- Prior art date
Links
- 208000028552 Treatment-Resistant Depressive disease Diseases 0.000 title 1
- 239000003693 atypical antipsychotic agent Substances 0.000 title 1
- 229940127236 atypical antipsychotics Drugs 0.000 title 1
- 238000002648 combination therapy Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229940126570 serotonin reuptake inhibitor Drugs 0.000 title 1
- 239000003772 serotonin uptake inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Percussion Or Vibration Massage (AREA)
- Medicines Containing Plant Substances (AREA)
- Compositions Of Oxide Ceramics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8644498P | 1998-05-22 | 1998-05-22 | |
| PCT/US1999/011276 WO1999061027A1 (en) | 1998-05-22 | 1999-05-21 | Combination therapy for treatment of refractory depression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL139592A0 IL139592A0 (en) | 2002-02-10 |
| IL139592A true IL139592A (en) | 2005-08-31 |
Family
ID=22198612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13959299A IL139592A (en) | 1998-05-22 | 1999-05-21 | Pharmaceutical composition containing an atypical antipsychotic and a serotonin reuptake inhibitor for combination therapy of refractory depression |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP0958824A3 (https=) |
| JP (1) | JP2002516282A (https=) |
| KR (1) | KR20010043730A (https=) |
| CN (1) | CN1154496C (https=) |
| AU (1) | AU761510B2 (https=) |
| BR (1) | BR9911049A (https=) |
| CA (1) | CA2332814C (https=) |
| CZ (1) | CZ20004279A3 (https=) |
| EA (1) | EA004539B1 (https=) |
| HK (1) | HK1040055B (https=) |
| HR (1) | HRP20000797A2 (https=) |
| HU (1) | HUP0101901A3 (https=) |
| ID (1) | ID26861A (https=) |
| IL (1) | IL139592A (https=) |
| MY (1) | MY127938A (https=) |
| NO (1) | NO20005885L (https=) |
| NZ (1) | NZ507980A (https=) |
| PL (1) | PL344331A1 (https=) |
| SK (1) | SK17512000A3 (https=) |
| TR (1) | TR200003443T2 (https=) |
| TW (1) | TWI226829B (https=) |
| UA (1) | UA78181C2 (https=) |
| WO (1) | WO1999061027A1 (https=) |
| ZA (1) | ZA200006815B (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1133299A1 (en) * | 1998-11-23 | 2001-09-19 | Sepracor Inc. | 2-hydroxymethylolanzapine compositions and methods |
| EP1396267A3 (en) * | 1999-12-06 | 2004-04-21 | H. Lundbeck A/S | The combination of a serotonin reuptake inhibitor and a 5-HT2C antagonist, inverse agonist or partial agonist |
| UA77650C2 (en) * | 1999-12-06 | 2007-01-15 | Lundbeck & Co As H | Use of serotonin reuptake inhibitor in combination with deramcyclane |
| CA2431041A1 (en) * | 2001-01-02 | 2002-07-11 | Pharmacia & Upjohn Company | New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents |
| CA2529857A1 (en) | 2002-07-30 | 2004-02-05 | Peter Migaly | Combination therapy for depression, prevention of suicide, and varous medical and psychiatric conditions |
| GB0229583D0 (en) * | 2002-12-19 | 2003-01-22 | Cipla Ltd | A process for preparing duloxetine and intermediates for use therein |
| KR100842694B1 (ko) | 2002-12-27 | 2008-07-01 | 오쓰까 세이야꾸 가부시키가이샤 | 기분 장애 치료용 카르보스티릴 유도체 및 세로토닌 재흡수억제제 |
| AR042806A1 (es) | 2002-12-27 | 2005-07-06 | Otsuka Pharma Co Ltd | Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo |
| FR2851163B1 (fr) * | 2003-02-14 | 2007-04-27 | Utilisation de l'enantiomere dextrogyre du milnacipran pour la preparation d'un medicament | |
| WO2005023243A1 (en) * | 2003-09-04 | 2005-03-17 | H. Lundbeck A/S | The combination of a serotonin reuptake inhibitor and loxapine |
| ES2319539T3 (es) | 2003-09-17 | 2009-05-08 | Janssen Pharmaceutica Nv | Compuestos heterociclicos condensados como moduladores del receptor de serotonina. |
| EP1713486A4 (en) * | 2003-12-02 | 2009-04-29 | Sheldon Leslie James | COMBINED THERAPY FOR THE TREATMENT OF DEMENTIA, DEPRESSION AND APATHY |
| WO2005056056A2 (en) * | 2003-12-15 | 2005-06-23 | H. Lundbeck A/S | The combination of a serotonin reuptake inhibitor and a histamine 3 receptor antagonist, inverse agonist or partial agonist |
| US7598255B2 (en) | 2005-08-04 | 2009-10-06 | Janssen Pharmaceutica Nv | Pyrimidine compounds as serotonin receptor modulators |
| EP2275095A3 (en) * | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| PL2044043T5 (pl) | 2006-06-16 | 2022-05-02 | H. Lundbeck A/S | Bromowodorek 1-[2-(2,4-dimetylofenylosulfanylo)fenylo]piperazyny jako związek o połączonym działaniu wychwytu zwrotnego serotoniny i działaniu na 5-ht3 i 5-ht1a do leczenia upośledzenia funckji poznawczych |
| PL2120878T3 (pl) * | 2007-02-09 | 2015-01-30 | Alphapharm Pty Ltd | Postać dawkowania zawierająca dwa czynne składniki farmaceutyczne o różnych postaciach fizycznych |
| TWI432194B (zh) * | 2007-03-20 | 2014-04-01 | Lundbeck & Co As H | ４-〔２-（４-甲基苯硫基）苯基〕哌啶之新穎治療用途 |
| US20140206667A1 (en) | 2012-11-14 | 2014-07-24 | Michela Gallagher | Methods and compositions for treating schizophrenia |
| CN105769875A (zh) * | 2014-12-22 | 2016-07-20 | 扬子江药业集团上海海尼药业有限公司 | 复方奥氮平盐酸氟西汀胶囊的制备方法 |
| CN108938645A (zh) * | 2018-08-24 | 2018-12-07 | 山西医科大学第医院 | 一种抗精神病药物组合物 |
| CN111084778B (zh) * | 2019-12-31 | 2022-06-24 | 北京鑫开元医药科技有限公司 | 一种奥氮平盐酸氟西汀胶囊及其制备方法 |
| CN114569566A (zh) * | 2020-12-02 | 2022-06-03 | 四川科瑞德制药股份有限公司 | 一种盐酸米那普仑制剂的制备方法 |
| ES3054324A1 (es) * | 2024-07-12 | 2026-02-02 | Univ Malaga | Galanina (1-15) y Fluoxetina en el tratamiento de la depresión resistente al tratamiento |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU8072691A (en) * | 1990-06-28 | 1992-01-23 | Beecham Group Plc | Pharmaceutical preparations |
| FR2716680B1 (fr) * | 1994-02-25 | 1996-04-05 | Adir | Nouveaux dérivés de benzodioxane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
| HUP9903679A3 (en) * | 1996-03-11 | 2001-10-29 | Lilly Co Eli | Use of olanzapine for the preparation of pharmaceutical compositions treating bipolar disorder |
| UA48219C2 (uk) * | 1996-03-25 | 2002-08-15 | Елі Ліллі Енд Компані | Композиція для вгамування болю (варіанти) та спосіб вгамування болю |
| ZA977967B (en) * | 1996-09-23 | 1999-03-04 | Lilly Co Eli | Combination therapy for treatment of psychoses |
-
1999
- 1999-05-21 HU HU0101901A patent/HUP0101901A3/hu unknown
- 1999-05-21 IL IL13959299A patent/IL139592A/xx not_active IP Right Cessation
- 1999-05-21 TR TR2000/03443T patent/TR200003443T2/xx unknown
- 1999-05-21 UA UA2000116623A patent/UA78181C2/uk unknown
- 1999-05-21 MY MYPI99002017A patent/MY127938A/en unknown
- 1999-05-21 ID IDW20002339A patent/ID26861A/id unknown
- 1999-05-21 HR HR20000797A patent/HRP20000797A2/hr not_active Application Discontinuation
- 1999-05-21 JP JP2000550487A patent/JP2002516282A/ja active Pending
- 1999-05-21 EP EP99303969A patent/EP0958824A3/en not_active Withdrawn
- 1999-05-21 KR KR1020007013059A patent/KR20010043730A/ko not_active Abandoned
- 1999-05-21 EA EA200001218A patent/EA004539B1/ru not_active IP Right Cessation
- 1999-05-21 WO PCT/US1999/011276 patent/WO1999061027A1/en not_active Ceased
- 1999-05-21 SK SK1751-2000A patent/SK17512000A3/sk unknown
- 1999-05-21 BR BR9911049-0A patent/BR9911049A/pt not_active Application Discontinuation
- 1999-05-21 CZ CZ20004279A patent/CZ20004279A3/cs unknown
- 1999-05-21 HK HK02101563.3A patent/HK1040055B/zh not_active IP Right Cessation
- 1999-05-21 AU AU40086/99A patent/AU761510B2/en not_active Ceased
- 1999-05-21 CN CNB998090719A patent/CN1154496C/zh not_active Expired - Fee Related
- 1999-05-21 CA CA002332814A patent/CA2332814C/en not_active Expired - Fee Related
- 1999-05-21 NZ NZ507980A patent/NZ507980A/en unknown
- 1999-05-21 TW TW088108382A patent/TWI226829B/zh not_active IP Right Cessation
- 1999-05-21 PL PL99344331A patent/PL344331A1/xx not_active Application Discontinuation
-
2000
- 2000-11-21 NO NO20005885A patent/NO20005885L/no unknown
- 2000-11-21 ZA ZA200006815A patent/ZA200006815B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MY127938A (en) | 2007-01-31 |
| EA200001218A1 (ru) | 2001-06-25 |
| ID26861A (id) | 2001-02-15 |
| WO1999061027A1 (en) | 1999-12-02 |
| EA004539B1 (ru) | 2004-06-24 |
| NZ507980A (en) | 2003-10-31 |
| HK1040055A1 (en) | 2002-05-24 |
| SK17512000A3 (sk) | 2002-02-05 |
| CZ20004279A3 (cs) | 2001-09-12 |
| PL344331A1 (en) | 2001-11-05 |
| UA78181C2 (en) | 2007-03-15 |
| CA2332814A1 (en) | 1999-12-02 |
| KR20010043730A (ko) | 2001-05-25 |
| JP2002516282A (ja) | 2002-06-04 |
| CN1311681A (zh) | 2001-09-05 |
| EP0958824A2 (en) | 1999-11-24 |
| AU761510B2 (en) | 2003-06-05 |
| HUP0101901A2 (hu) | 2001-11-28 |
| IL139592A0 (en) | 2002-02-10 |
| CN1154496C (zh) | 2004-06-23 |
| BR9911049A (pt) | 2001-02-06 |
| AU4008699A (en) | 1999-12-13 |
| HRP20000797A2 (en) | 2001-10-31 |
| HUP0101901A3 (en) | 2002-06-28 |
| TWI226829B (en) | 2005-01-21 |
| EP0958824A3 (en) | 1999-12-01 |
| ZA200006815B (en) | 2002-01-14 |
| HK1040055B (zh) | 2005-04-01 |
| CA2332814C (en) | 2008-11-04 |
| TR200003443T2 (tr) | 2001-03-21 |
| NO20005885D0 (no) | 2000-11-21 |
| NO20005885L (no) | 2001-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL139592A (en) | Pharmaceutical composition containing an atypical antipsychotic and a serotonin reuptake inhibitor for combination therapy of refractory depression | |
| ZA987800B (en) | Pharmaceutical composition of meloxicam | |
| HUP0002183A3 (en) | Pharmaceutical composition for combination of piperidinoalkanol-decongestant | |
| CA2264941A1 (en) | Use of a combination of an atypical antipsychotic and a serotonin reuptake inhibitor for treatment of psychosis | |
| SG60073A1 (en) | Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors | |
| PL352282A1 (en) | Derivatives of thiazoles and pharmaceutical compositions containing these derivatives | |
| IL115315A0 (en) | Synthesis of 3-(4-(2-aminoethoxy)-benzoyl)-2-aryl-6-hydroxybenzo (b) thiophenes | |
| IL136086A0 (en) | New composition of matter | |
| IL127214A0 (en) | Inhibition of serotonin reuptake | |
| IL133605A0 (en) | Solid pharmaceutical composition containing benzofuran derivatives | |
| HUP0300534A3 (en) | Antitumoral ecteinascidin derivatives and pharmaceutical compositions containing them | |
| HUP0200602A3 (en) | Pharmaceutical compositions containing a combination of a 5-ht reuptake inhibitor and a h5-ht1b antagonist or partial agonist and their use | |
| PT1067941E (pt) | Composicao antitumoral contendo uma combinacao sinergica de um derivado de antraciclina com um derivado de camptotecina | |
| HUP0301830A3 (en) | Pharmaceutical composition containing a combination of fbpase inhibitors and antidiabetic agents useful for the treatment of diabetes | |
| IL154050A0 (en) | Pharmaceutical composition containing citalopram | |
| PL340456A1 (en) | Novel oral dosage form of carvedilol | |
| AU4307800A (en) | New indication for use of antiepileptic agents and medicines | |
| HU0103939D0 (en) | Pharmaceutical composition containing methformin and n-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride | |
| IL144027A0 (en) | A pharmaceutical composition containing a pre-activation domain and at least one kringle region from plasminogen | |
| HUP0203383A3 (en) | Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof | |
| EP0996441A4 (en) | PHARMACEUTICAL COMPOSITIONS OF ARGLABIN AND ARGLABIN DERIVATIVES | |
| HUP0303497A3 (en) | Pharmaceutical compositions containing combination of statins and sorbitol dehydrogenase inhibitors | |
| HUP0201135A3 (en) | Substituted benzolactam compounds, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them | |
| HUP0303136A3 (en) | New use of iloperidone and pharmaceutical composition containing it | |
| IL129220A0 (en) | A pharmaceutical composition for lowering plasma levels of lipoprotein (a) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NP | Permission for amending the patent specification granted (section 66, patents law 1967) | ||
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |